CAJ | 학술논문

目的探讨Ahmed青光眼引流阀植入术治疗玻璃体切割术后青光眼的疗效及其安全性.方法对12例(12眼)因视网膜脱离已行玻璃体切割术后发生青光眼的患者行Ahmed青光眼引流阀植入术,术后随访3～6个月,平均为(4.7±1.2)个月.结果 12眼术前眼压为30.5～50.7 mmHg(1 mmHg=0.133 kPa),平均为(40.5±10.2)mmHg;术后随防期内,眼压为8.0～21.0 mmHg,平均为(13.5±4.3)mmHg.手术成功率为100%.除2眼在术后2周时因引流管阻塞而行冲洗再通外,无其他术后并发症发生.结论对于玻璃体切割术后药物无法有效控制眼压的青光眼患者,Ahmed引流阀植入术是一种有效、安全的治疗方法.
목적 탐토Ahmed청광안인류벌식입술치료파리체절할술후청광안적료효급기안전성.방법 대12례(12안)인시망막탈리이행파리체절할술후발생청광안적환자행Ahmed청광안인류벌식입술,술후수방3～6개월,평균위(4.7±1.2)개월.결과 12안술전안압위30.5～50.7 mmHg(1 mmHg=0.133 kPa),평균위(40.5±10.2)mmHg;술후수방기내,안압위8.0～21.0 mmHg,평균위(13.5±4.3)mmHg.수술성공솔위100%.제2안재술후2주시인인류관조새이행충세재통외,무기타술후병발증발생.결론 대우파리체절할술후약물무법유효공제안압적청광안환자,Ahmed인류벌식입술시일충유효、안전적치료방법.
Objective To evaluate the efficacy and safety of Ahmed glaucoma valve implantation for glaucoma following vitrectomy surgery. Methods Twelve patients (12 eyes) who had been diagnosed with glaucoma after vitrectomy and phacoemulsification surgery due to retina detachment were selected in this study.The 12 eyes were treated with Ahmed glaucoma valve implant surgery, and the patients were followed up for (4.7±1.2) months(ranging 3-6 months). Results The mean intraocular pressure decreased from (40.5±10.2) mmHg(1 mmHg=0. 133 kPa) before the implant surgery (ranging 30.5-50. 7 mmHg) to (13. 5±4.3) mmHg after the surgery (ranging 8.0-21.0 mmHg). The successful rate of the implant surgery was 100 %. Two eyes had obstruction of drainage tube 2 weeks after the surgery and were recanalized after rinsing, with no other complications. Conclusion Ahmed glaucoma valve implant is effective and safe for glaucoma after vitrectomy.